Press Releases

No. 01a | 03. January 2017 | by Koh

DKFZ-researcher receives ERC-Grant

Aurelio Teleman
© Tobias Schwerdt, DKFZ

ERC Consolidator Grants by the European Research Council (ERC) support excellent researchers to help them consolidate their independent careers. Aurelio Teleman from the German Cancer Research Center (DKFZ) recently received a Consolidator Grant, which is already the second prestigious ERC grant that he was able to attract. The grant comprising €2 million will enable Teleman to investigate how a fatty acid from food controls cellular growth as a signaling molecule and may even play a role in the development of cancer.

read more

No. 52c | 19. December 2016 | by HF/Sel

Alina Steinbach receives the Nicola Werner Prize for cancer research

Alina Steinbach has been awarded the first Nicola Werner Prize
© Tobias Schwerdt, DKFZ

In her doctoral thesis, Alina Steinbach identified a mechanism by which HPV-positive tumor cells manage to escape an attack of the immune system. On Friday 16 December 2016, she received the Nicola Werner Prize for her work. For the 2000 Euro prize money, family and friends of the artist Nicola Werner, who died from HPV-related cancer, pedaled hard in a sponsored cycling marathon- continuing Nicola Werner's mission: to drive preventive work and research into human papillomavirus (HPV) forward.

read more

No. 53 | 20. December 2016 | by Koh

Programmable gene scissors revolutionize life sciences

Emmanuelle Charpentier
© dkfz.de

The Meyenburg Prize 2016 endowed with 50,000 Euros goes to the microbiologist Emmanuelle Charpentier from the Max Planck Institute for Infection Biology in Berlin. She receives the award for her breakthrough work in developing programmable "gene scissors". This new technology that makes genetic manipulation fast and simple. The Meyenburg Prize will be presented during a symposium at the German Cancer Research Center on Tuesday, 20 December 2016.

read more

No. 47b | 23. November 2016

Hopp Children's Tumor Center at NCT Heidelberg ready to start

Prof. Dr. Andreas Kulozik, Prof. Dr. Olaf Witt, Dietmar Hopp, Annika, Prof....
© Universitätsklinikum Heidelberg

Heidelberg University Hospital and the German Cancer Research Center (DKFZ) have founded the Hopp-Kindertumorzentrum at the NCT* Heidelberg, in short: KiTZ, a tumor center for therapy and research in pediatric oncology and hematology. Their aim is to create new diagnostic and therapeutic options to help children with cancer more effectively. The Dietmar Hopp Foundation will support the project with 20 million Euros towards the construction of the new center, as SAP founder and patron Dietmar Hopp announced at a press conference on November 23.

read more

No. 52a | 14. December 2016 | by Koh

Using sound and light for navigating inside the body - Lena Maier-Hein has been awarded the Emil Salzer Prize

Priv.-Doz. Dr. Lena Maier-Hein was awarded the 2016 Dr. Emil Salzer Prize
© Uwe Anspach, DKFZ

When performing minimally invasive surgery, clinicians need to have imaging information from inside the body for spatial orientation and in order to differentiate malignant tissue from healthy tissue. Novel imaging methods based on sound and light provide additional imaging information that goes far beyond the images that a normal endoscopic camera can provide. Lena Maier-Hein from the German Cancer Research Center (DKFZ) now receives the 2016 Emil Salzer Prize for enhancing these methods.

read more

No. 52 | 07. December 2016 | by Koh

New paths in drug research

A compound binds to an enzyme and inhibits its function
© Aubry Miller, DKFZ

The need for novel drugs has never been greater. Average lifespans are increasing and the demand for new medications against common diseases such as cancer, diabetes, and dementia is continuously rising. The discovery of new drugs, once an almost exclusive realm of the pharmaceutical industry, is now increasingly being performed in research institutions. Therefore, the Helmholtz Drug Research Initiative is hosting its first public conference on this topic at the German Cancer Research Center (DKFZ) on December 8 and 9, 2016.

read more

No. 48 | 24. November 2016 | by AM

DKTK Essen /Düsseldorf: Essen Physicians Receive Prize for Best Studies on Carcinogenesis and Cancer Treatment

Prof. Helmut Oettle, Prof. Volker Heinemann, Prof. Jens Siveke and Prof. Fl...
© AIO

Two scientists of the German Cancer Consortium (DKTK) have received the highest award by the Oncology in Internal Medicine Working Group (AIO) of the German Cancer Society. The physicians Wilfried Eberhardt and Jens Siveke of the medical faculty of the University of Duisburg-Essen (UDE) at the West German Tumor Center (WTZ) of the University Hospital of Essen (UK Essen) are receiving the award for “best scientific publication” and “best clinical study” for their research on lung and pancreatic cancer.

read more

No. 51 | 01. December 2016 | by Koh

DKTK Tübingen: €2.5 million for developing a novel cancer immunotherapy

Tumor cells coated with bispecific antibodies are attacked and killed by ac...
© J.Chiu, G.Jung

Scientists from the German Cancer Consortium (DKTK) at Tübingen University Hospital have developed a promising bispecific antibody for use in immunotherapy of prostate cancer and so-called squamous cell carcinoma, which can occur, for example, in the lungs, skin or uterus. The antibody binds to cancer cells as well as immune cells, thus provoking an immune response against the tumor. The Helmholtz Association now provides €2.5 million from its validation fund for the purpose of executing the next steps in the pharmaceutical development of the bispecific antibody.In the German Cancer Consortium (DKTK), the German Cancer Research Center (DKFZ) in Heidelberg joins up as a core center in long-term collaborations with university institutes and hospitals all over Germany that are specialized in research and treatment with a focus on oncology.

read more

No. 47 | 21. November 2016 | by ah

30 Years of the Cancer Information Service: More important than ever before!

What patients ask: Breast and prostate cancer are the most asked about.
© dkfz.de

Every year, more and more people are afflicted by cancer. In 2015 there were about 490,000 new cases in Germany alone. So, it is not surprising that the need for reliable information continues to grow: Last year, the German Cancer Information Service (KID) of the German Cancer Research Center (DKFZ) responded to 34,000 individual enquiries from all across Germany – more than ever before. Every month between 450,000 and 635,000 users accessed information on the website www.krebsinformationsdienst.de. Since 2014, doctors, caregivers, therapists and psychological counselors have utilized and valued the professional service krebsinformationsdienst.med.

read more

No. 46 | 14. November 2016 | by Koh

Research to combat pancreatic cancer

Illustration of the pancreas
© Wellcome Library, London

Cancer of the pancreas is one of the most aggressive types of cancer and therapies currently used are usually rather ineffective. Therefore, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg are very committed in the fight against this disease. They discovered what makes this cancer type so resistant against drugs and why the tumors spread outside the pancreas so early. Based on these findings, they are testing schizophrenia medications, novel agents and even viruses in the treatment of pancreatic cancer.

read more

RSS-Feed

Subscribe to our RSS-Feed.

to top